(Q37523952)

English

Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.

scientific article published on August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538001%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

Europe PubMed Central

Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538001%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

arterial hypertension

0 references

hydrochlorothiazide

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538001%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Peter Bramlage

1

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

language of work or name

0 references

publication date

1 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538001%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Expert Opinion on Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538001%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538001%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538001%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1755-1767

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538001%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Impact of high-normal blood pressure on the risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Worldwide prevalence of hypertension: a systematic review

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

High prevalence and poor control of hypertension in primary care: cross-sectional study.

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Treatment of hypertension in patients 80 years of age or older

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Efficacy and safety of two treatment combinations of hypertension in very elderly patients

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Effectiveness of add-on low-dose diuretics in combination therapy for hypertension: losartan/hydrochlorothiazide vs. candesartan/amlodipine

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Amlodipine/Valsartan: fixed-dose combination in hypertension

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

2007 Guidelines for the Management of Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Patterns of antihypertensive drug utilization in primary care

1 reference

https://api.crossref.org/works/10.1517%2F14656560903036103

21 January 2018

Identifiers

10.1517/14656560903036103

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538001%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538001%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37523952&oldid=2149276207"